<bill session="116" type="h" number="6238" updated="2022-02-08T23:17:31Z">
  <state datetime="2020-03-12">REFERRED</state>
  <status>
    <introduced datetime="2020-03-12"/>
  </status>
  <introduced datetime="2020-03-12"/>
  <titles>
    <title type="display">Cameron&#226;&#8364;&#8482;s Law</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to restore the amount of the orphan drug tax credit, and for other purposes.</title>
    <title type="short" as="introduced">Cameron&#226;&#8364;&#8482;s Law</title>
  </titles>
  <sponsor bioguide_id="G000583"/>
  <cosponsors>
    <cosponsor bioguide_id="U000031" joined="2020-03-12"/>
  </cosponsors>
  <actions>
    <action datetime="2020-03-12">
      <text>Introduced in House</text>
    </action>
    <action datetime="2020-03-12" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2020-03-12">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
    <term name="Business expenses"/>
    <term name="Congressional oversight"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Government studies and investigations"/>
    <term name="Income tax credits"/>
    <term name="Medical research"/>
    <term name="Medical tests and diagnostic methods"/>
    <term name="Research and development"/>
  </subjects>
  <amendments/>
  <summary date="2020-04-01T12:46:03Z" status="Introduced in House">Cameron's Law

This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit).

The bill also requires the Centers for Disease Control and Prevention to complete a study and report on enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.</summary>
</bill>
